Why Gene-Editing Pioneer Editas Skyrocketed 28.8% in August – Madison.com
Madison.com |
Why Gene-Editing Pioneer Editas Skyrocketed 28.8% in August
Madison.com Editas Medicine also said it bolstered its patent portfolio by adding a patent for CRISPR–Cpf1, a second gene-editing approach that could increase the number of genomic sites that can be edited, simplify manufacturing, and improve gene repair versus … |
